MedPath
HSA Approval

CENVITE TABLET

SIN07046P

CENVITE TABLET

CENVITE TABLET

June 5, 1992

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantCENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Licence HolderCENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AD01

ordinary salt combinations

Manufacturer Information

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

SIMETHICONE

30 mg

Simethicone

ALUMINIUM HYDROXIDE (DRIED GEL)

250 mg

Aluminum hydroxide

MAGNESIUM TRISILICATE

250 mg

Magnesium trisilicate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CENVITE TABLET - HSA Approval | MedPath